首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Novel N-phenyl dichloroacetamide derivatives as anticancer reagents: design, synthesis and biological evaluation.
【24h】

Novel N-phenyl dichloroacetamide derivatives as anticancer reagents: design, synthesis and biological evaluation.

机译:新型N-苯基二氯乙酰胺衍生物作为抗癌剂:设计,合成和生物学评估。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

A current study shows that sodium dichloroacetate (DCA) can induce cancer cell apoptosis and inhibit tumor growth, but its cytotoxic activity is low (IC(50) > 1000 microM for A549). In this paper, a variety of DCA derivatives were synthesized, and their cytotoxic activities were evaluated. The result showed that the N-phenyl-2,2-dichloroacetamide analogues had satisfactory potencies. Among them, N-(3-iodophenyl)-2,2-dichloroacetamide (3e), an optimized lead compound, has an IC(50) against A549 as low as 4.76 microM. Furthermore, it can induce cancer cell apoptosis and has a low toxicity in mice (LD(50) = 1117 mg/kg).
机译:当前的研究表明,二氯乙酸钠(DCA)可以诱导癌细胞凋亡并抑制肿瘤的生长,但其细胞毒活性较低(A549的IC(50)> 1000 microM)。本文合成了多种DCA衍生物,并对它们的细胞毒性进行了评估。结果表明,N-苯基-2,2-二氯乙酰胺类似物具有令人满意的效力。其中,优化的先导化合物N-(3-碘苯基)-2,2-二氯乙酰胺(3e)对A549的IC(50)低至4.76 microM。此外,它可以诱导癌细胞凋亡,并且对小鼠的毒性低(LD(50)= 1117 mg / kg)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号